Data as at IST. Index data may be delayed by up to 20 minutes. For real-time updates, kindly refer to the BSE and NSE websites.
As insurance companies rush to take advantage of a change in ownership rules
The dairy company is looking to raise Rs 300 cr by issue of fresh equity in the IPO
Overall expenses grew 19% to Rs 419 cr over the previous year
BSE plans to file its offer document with Sebi by July, say sources
The valuation would be based on the performance in 2015-16
The Rs 767 crore IPO is priced between Rs 220 - Rs 227
Philips said it would retain the majority stake in the lighting arm "with the aim to fully sell down over the next several years" as it shifts its focus to healthcare products
Continued investments in facilities, products and branding will keep profitability
The 29.7 million shares on offer saw bids for 1.2 billion shares worth Rs 25,200 crore, despite no participation by foreign investors
The share sale would help Ujjivan Financial Services bring down the foreign shareholding to around 45% from the current 77%
Also picks ICICI Securities, HSBC and Deutsche Bank as joint book-runners
It is expected to be a combination of offer-for-sale and issuance of fresh equity
Thyrocare Technologies to be listed on BSE and NSE in seven working days
The medical diagnostics company's Rs 480-crore IPO closes on Friday
Dr Lal Pathlabs, which came out with its IPO at Rs 550 per share, was listed at a 30% premium at Rs 720 and touched a high of Rs 1,045 a few weeks ago
Home-grown telecom equipment company crosses $100 mn in revenues in FY16
Thyrocare has allocated 32,23,411 shares to 15 anchor investors at Rs 446 per share
Given the strong financials and track record, long-term investors could consider the offer
NBFCs are witnessing spurt in demand for loans to invest in IPOs following success of Equitas, attractive grey market premiums